Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Faxc | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of FAXC mRNA | CTD | PMID:29097150 | Faxc | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Faxc (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin affects the methylation of FAXC intron] which results in increased expression of FAXC mRNA | CTD | PMID:33017471 | Faxc | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Faxc | Rat | aldehydo-D-glucose | multiple interactions | ISO | Faxc (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Faxc | Rat | all-trans-retinoic acid | increases expression | ISO | FAXC (Homo sapiens) | 6480464 | Tretinoin results in increased expression of FAXC mRNA | CTD | PMID:23724009 | Faxc | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FAXC mRNA | CTD | PMID:35163327 | Faxc | Rat | antirheumatic drug | increases expression | ISO | FAXC (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of FAXC mRNA | CTD | PMID:24449571 | Faxc | Rat | arsane | multiple interactions | ISO | FAXC (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Faxc | Rat | arsenic atom | multiple interactions | ISO | FAXC (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Faxc | Rat | benzo[a]pyrene | increases methylation | ISO | FAXC (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of FAXC 3' UTR | CTD | PMID:27901495 | Faxc | Rat | benzo[a]pyrene | affects methylation | ISO | FAXC (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of FAXC promoter | CTD | PMID:27901495 | Faxc | Rat | beta-lapachone | increases expression | ISO | FAXC (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of FAXC mRNA | CTD | PMID:38218311 | Faxc | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Faxc (Mus musculus) | 6480464 | [Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in increased expression of FAXC more ... | CTD | PMID:33484791 | Faxc | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FAXC mRNA | CTD | PMID:25181051 | Faxc | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Faxc | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of FAXC gene | CTD | PMID:28505145 | Faxc | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Faxc | Rat | butanal | decreases expression | ISO | FAXC (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of FAXC mRNA | CTD | PMID:26079696 | Faxc | Rat | chlorpyrifos | decreases expression | ISO | Faxc (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of FAXC mRNA | CTD | PMID:37019170 | Faxc | Rat | cisplatin | multiple interactions | ISO | FAXC (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of FAXC mRNA | CTD | PMID:27392435 | Faxc | Rat | cisplatin | decreases expression | ISO | FAXC (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of FAXC mRNA | CTD | PMID:27392435 | Faxc | Rat | copper atom | multiple interactions | ISO | FAXC (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FAXC mRNA | CTD | PMID:20971185 | Faxc | Rat | copper(0) | multiple interactions | ISO | FAXC (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FAXC mRNA | CTD | PMID:20971185 | Faxc | Rat | D-glucose | multiple interactions | ISO | Faxc (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Faxc | Rat | entinostat | decreases expression | ISO | FAXC (Homo sapiens) | 6480464 | entinostat results in decreased expression of FAXC mRNA | CTD | PMID:27188386 | Faxc | Rat | ethanol | affects splicing | ISO | Faxc (Mus musculus) | 6480464 | Ethanol affects the splicing of FAXC mRNA | CTD | PMID:30319688 | Faxc | Rat | fructose | multiple interactions | ISO | Faxc (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Faxc | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of FAXC mRNA | CTD | PMID:33387578 | Faxc | Rat | glucose | multiple interactions | ISO | Faxc (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Faxc | Rat | ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of FAXC mRNA | CTD | PMID:20080153 | Faxc | Rat | manganese atom | multiple interactions | ISO | FAXC (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Faxc | Rat | manganese(0) | multiple interactions | ISO | FAXC (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Faxc | Rat | manganese(II) chloride | multiple interactions | ISO | FAXC (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Faxc | Rat | nickel atom | decreases expression | ISO | FAXC (Homo sapiens) | 6480464 | Nickel results in decreased expression of FAXC mRNA | CTD | PMID:25583101 | Faxc | Rat | nickel sulfate | increases expression | ISO | FAXC (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of FAXC mRNA | CTD | PMID:22714537 | Faxc | Rat | okadaic acid | increases expression | ISO | FAXC (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of FAXC mRNA | CTD | PMID:38832940 | Faxc | Rat | panobinostat | affects expression | ISO | FAXC (Homo sapiens) | 6480464 | panobinostat affects the expression of FAXC mRNA | CTD | PMID:26733615 | Faxc | Rat | panobinostat | multiple interactions | ISO | FAXC (Homo sapiens) | 6480464 | (+)-JQ1 compound promotes the reaction [panobinostat affects the expression of FAXC mRNA]; panobinostat promotes the more ... | CTD | PMID:26733615 | Faxc | Rat | pentanal | decreases expression | ISO | FAXC (Homo sapiens) | 6480464 | pentanal results in decreased expression of FAXC mRNA | CTD | PMID:26079696 | Faxc | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FAXC mRNA | CTD | PMID:35163327 | Faxc | Rat | propionic acid | decreases expression | ISO | FAXC (Homo sapiens) | 6480464 | propionic acid results in decreased expression of FAXC mRNA | CTD | PMID:31526819 | Faxc | Rat | sodium arsenite | decreases expression | ISO | FAXC (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of FAXC mRNA | CTD | PMID:38568856 | Faxc | Rat | sodium arsenite | multiple interactions | ISO | FAXC (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Faxc | Rat | streptozocin | multiple interactions | ISO | Faxc (Mus musculus) | 6480464 | [Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in increased expression of FAXC more ... | CTD | PMID:33484791 | Faxc | Rat | sunitinib | decreases expression | ISO | FAXC (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of FAXC mRNA | CTD | PMID:31533062 | Faxc | Rat | temozolomide | increases expression | ISO | FAXC (Homo sapiens) | 6480464 | Temozolomide results in increased expression of FAXC mRNA | CTD | PMID:31758290 | Faxc | Rat | testosterone | decreases expression | ISO | FAXC (Homo sapiens) | 6480464 | Testosterone results in decreased expression of FAXC mRNA | CTD | PMID:33359661 | Faxc | Rat | thiram | decreases expression | ISO | FAXC (Homo sapiens) | 6480464 | Thiram results in decreased expression of FAXC mRNA | CTD | PMID:38568856 | Faxc | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of FAXC mRNA | CTD | PMID:33387578 | Faxc | Rat | valproic acid | decreases expression | ISO | FAXC (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of FAXC mRNA | CTD | PMID:27188386 | Faxc | Rat | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of FAXC mRNA | CTD | PMID:29427782 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















